Our Science
Our Platform
ceDNA
ctLNP
Enzymatic Manufacturing
Our Scientific Presentations
Our Portfolio
An Overview
Liver
Retina
Early Research
Expansion Areas
Our Culture
Who We Are
Leadership
A Shared Vision
Investor Center
Join Us
Blog
News
Contact
Menu
In the news
Press Releases
March 2, 2022
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
February 24, 2022
Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
February 10, 2022
Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer
January 5, 2022
Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference
« Previous
1
2
2021
May 27, 2021
Generation Bio to Present at the Jefferies Virtual Healthcare Conference
May 12, 2021
Generation Bio Presents Preclinical Data Demonstrating Broad Potential of Gene Therapy Platform at ASGCT and Reports First Quarter Financial Results
April 27, 2021
Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting
April 8, 2021
Generation Bio to Present at 20th Annual Needham Virtual Healthcare Conference
March 18, 2021
Generation Bio Reports Fourth Quarter and Full Year 2020 Financial Results
February 18, 2021
Generation Bio Appoints Ron Cooper to Its Board of Directors
January 11, 2021
Generation Bio Announces Closing of Public Offering
January 6, 2021
Generation Bio Announces Pricing of Public Offering
January 5, 2021
Generation Bio to Present at 39th Annual J.P. Morgan Healthcare Conference
January 4, 2021
Generation Bio Announces Two Non-Viral Gene Therapy Milestone Achievements: Target Levels of Factor VIII Expression in Hemophilia A Mice and Translation of Expression from Mice to Non-Human Primates
« Previous
1
2
2020
January 10, 2020
Generation Bio to Present at 38th Annual J.P. Morgan Healthcare Conference
« Previous
1
2
2019
2018
January 4, 2018
Atlas Venture Launches Generation Bio
« Previous
1
2
Twitter
Tweets by GenerationBio
Media Contact
media@generationbio.com
Investor Relations Contact
investors@generationbio.com
Follow us on Twitter
Follow us on Linkedin
close
arrow-circle-o-down
arrow-down
bars
ellipsis-v
cross
